Health
FDA proposes new regulatory framework on artificial intelligence, machine learning technologies – News-Medical.Net
The findings come from a cross-sectional study, published in BMJ Open, of the comments submitted to the US Food and Drug Administration (FDA) ‘Proposed Regulato…
Reviewed by Emily Henderson, B.Sc.Oct 16 2020
The findings come from a cross-sectional study, published in BMJ Open, of the comments submitted to the US Food and Drug Administration (FDA) ‘Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD)–Discussion Paper and Request for Feedback’.
Artificial intelligence (AI) and machine learning (ML) technologies have the potential to transform health care, continual…
-
Noosa News16 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business18 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Business19 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
General14 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse